Kathleen Laporte
Director, ISTA PHARMACEUTICALS INC.
Companies
- Q32 Bio Inc.Board member Mar 27, 2024 to now1
- 89bio, Inc.Board member Nov 3, 2021 to now2
- CERO THERAPEUTICS HOLDINGS, INC.Board member Oct 5, 2021 to now3
- Bolt Biotherapeutics, Inc.Board member Feb 4, 2021 to now4
- Precipio, Inc.Board member Aug 13, 2018 to now5
- Paratek Pharmaceuticals, Inc.Board member Feb 3, 2009 to Feb 2, 20126
- eHealthInsuranceBoard member Oct 12, 2006 to Oct 12, 20067
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Precipio, Inc. PRPO7,382 shares8$166.4K at $22.54Jan 15, 2026
- Q32 Bio Inc. QTTB5,431 shares9$42.2K at $7.77Mar 27, 2024
- CERO THERAPEUTICS HOLDINGS, INC. CERO971,825 shares10$6.1K at $0.01Oct 2, 2024
- 89bio, Inc.0 shares11Jul 17, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 15, 2026Granted 520 shares at $24.00 of Precipio, Inc.8
- Oct 15, 2025Granted 711 shares at $17.58 of Precipio, Inc.12
- Sep 8, 2025Sold 6,152 shares at $20.06 of Precipio, Inc.13
- Apr 15, 2025Granted 2,232 shares at $5.60 of Precipio, Inc.14
- Sep 25, 2024Exercised options 965,997 shares of CERO THERAPEUTICS HOLDINGS, INC.10
- Apr 15, 2024Granted 9,693 shares at $6.70 of Precipio, Inc.15
- Feb 14, 2024Other 5,828 shares of CERO THERAPEUTICS HOLDINGS, INC.16
- Sep 12, 2023Granted 7,575 shares of Precipio, Inc.17
- Jul 17, 2023Sold 12,500 shares at $18.80 of 89bio, Inc.11
- Jul 17, 2023Exercised options 12,500 shares at $2.64 of 89bio, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARQ32 Bio Inc., Board member
- 2SEC EDGAR89bio, Inc., Board member
- 3
- 4
- 5SEC EDGARPrecipio, Inc., Board member
- 6
- 7SEC EDGAReHealthInsurance, Board member
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Oct 16, 2025
- 13SEC EDGARForm 4 filed Sep 10, 2025
- 14SEC EDGARForm 4 filed Apr 17, 2025
- 15SEC EDGARForm 4 filed Apr 17, 2024
- 16SEC EDGARForm 4 filed Feb 16, 2024
- 17SEC EDGARForm 4 filed Sep 14, 2023